ReviewEpidemics2019
Fogarty International Center collaborative networks in infectious disease modeling: Lessons learnt in research and capacity building.
Review in Epidemics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 42 citations in OpenAlex.
- Impacts of Responsible Conduct of Research Education on the Career and Practice of Graduating Fellows.Journal of empirical research on human research ethics : JERHRE · 2026Article
- Pathways, outputs and impact of NIH-supported bioinformatics and genomics graduate trainees in Africa.Briefings in bioinformatics · 2026Review
- Capacity building for zoonosis control in China: Assessing needs and gaps by the one health lens.One health (Amsterdam, Netherlands) · 2025Article
- Navigating the Nexus of Bioethics and Geopolitics: Implications for Global Health Security and Scientific Collaboration.Journal of bioethical inquiry · 2025Article
- Transboundary determinants of avian zoonotic infectious diseases: challenges for strengthening research capacity and connecting surveillance networks.Frontiers in microbiology · 2024Review
- Global Health Perspectives on Race in Research: Neocolonial Extraction and Local Marginalization.International journal of environmental research and public health · 2023Review
- A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.Science (New York, N.Y.) · 2022Article
- Monitoring COVID-19 in Colombia during the first year of the pandemic.Journal of public health research · 2022Article
- Biodefence research two decades on: worth the investment?The Lancet. Infectious diseases · 2021Review
- Coordinating SARS-CoV-2 genomic surveillance in the United States.Virus evolution · 2021Article
- Strong spatial embedding of social networks generates nonstandard epidemic dynamics independent of degree distribution and clustering.Proceedings of the National Academy of Sciences of the United States of America · 2020Article
- A call to action: strengthening the capacity for data capture and computational modelling of HIV integrated care in low- and middle-income countries.Journal of the International AIDS Society · 2020Article
- Coordinating the real-time use of global influenza activity data for better public health planning.Influenza and other respiratory viruses · 2020Article
- Ontology-Based Graphs of Research Communities: A Tool for Understanding Threat Reduction Networks.Frontiers in research metrics and analytics · 2020Article
- A Case History in Cooperative Biological Research: Compendium of Studies and Program Analyses in Kazakhstan.Tropical medicine and infectious disease · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to a combination of ecological, political, and demographic factors, the emergence of novel pathogens has been increasingly observed in animals and humans in recent decades. Enhancing global capacity to study and interpret infectious disease surveillance data, and to develop data-driven computational models to guide policy, represents one of the most cost-effective, and yet overlooked, ways to prepare for the next pandemic. Epidemiological and behavioral data from recent pandemics and historic scourges have provided rich opportunities for validation of computational models, while new sequencing technologies and the 'big data' revolution present new tools for studying the epidemiology of outbreaks in real time. For the past two decades, the Division of International Epidemiology and Population Studies (DIEPS) of the NIH Fogarty International Center has spearheaded two synergistic programs to better understand and devise control strategies for global infectious disease threats. The Multinational Influenza Seasonal Mortality Study (MISMS) has strengthened global capacity to study the epidemiology and evolutionary dynamics of influenza viruses in 80 countries by organizing international research activities and training workshops. The Research and Policy in Infectious Disease Dynamics (RAPIDD) program and its precursor activities has established a network of global experts in infectious disease modeling operating at the research-policy interface, with collaborators in 78 countries. These activities have provided evidence-based recommendations for disease control, including during large-scale outbreaks of pandemic influenza, Ebola and Zika virus. Together, these programs have coordinated international collaborative networks to advance the study of emerging disease threats and the field of computational epidemic modeling. A global community of researchers and policy-makers have used the tools and trainings developed by these programs to interpret infectious disease patterns in their countries, understand modeling concepts, and inform control policies. Here we reflect on the scientific achievements and lessons learnt from these programs (h-index = 106 for RAPIDD and 79 for MISMS), including the identification of outstanding researchers and fellows; funding flexibility for timely research workshops and working groups (particularly relative to more traditional investigator-based grant programs); emphasis on group activities such as large-scale modeling reviews, model comparisons, forecasting challenges and special journal issues; strong quality control with a light touch on outputs; and prominence of training, data-sharing, and joint publications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.